Truvestments Capital’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-300
Closed -$18K – 718
2019
Q2
$18K Hold
300
– – 0.01% 446
2019
Q1
$20K Buy
+300
New +$19.7K 0.02% 398
2018
Q3
$29K Buy
+400
New +$28.7K 0.01% 461

Other funds holding PJP

Truvestments Capital's PJP Position: Q3 2019 in Review

Truvestments Capital sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2019, closing a stake of 300 shares — an estimated $18K sold.

Truvestments Capital first reported a position in PJP in Q3 2018 and held it in 3 quarters. The position peaked at $29K in Q3 2018. 83 funds tracked by Wall St. Rank hold PJP as of Q3 2019.

  • Truvestments Capital reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2019 after selling out during the quarter.
  • Truvestments Capital sold 300 Invesco Pharmaceuticals ETF shares in Q3 2019, an estimated $18K.
  • Truvestments Capital first reported a position in Invesco Pharmaceuticals ETF in Q3 2018 and held it in 3 quarters.
  • Truvestments Capital's Invesco Pharmaceuticals ETF position peaked at $29K in Q3 2018.
  • 83 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2019.

Based on Truvestments Capital's 13F filing for Q3 2019, filed 10 Oct 2019.